Drugs / TAK-188
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT07205718 | Nov 2025 → Dec 2028 expected | — | Takeda | Recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | TAK-188 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07205718 ↗ |
| Action | Deplete | “TAK-188 may help to remove these Tregs.” NCT07205718 ↗ |
| Route | Intravenous | “intravenously (IV) infusion” NCT07205718 ↗ |